Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Steven Rachbach who wrote (231)	10/6/1998 2:49:00 PM
From: Larry Dreher	Read Replies (1) \| Respond to of 1127

I believe that the first successful Phase II trial for one of its drugs will catapault HGSI into the spotlight and the rush to buy this stock will be tremendous. Any comments? I have to agree with you. I've seen the same explosive potential to this company for quite a while. Unfortunately people keep pouring money into the likes of yahoo and excite while the general biotech market is getting killed. I've also learned hard lessons in other biotechs about how slowly things really move. The clinical trails are bad enough, then the FDA gets involved and God only knows how long they will take to come to some sort of conclusion. I'm in here for the long run. I can see that this could easily be a $100 stock in 5 years, but for now all we can do is hang in and hope the market sees the same potential we do. Larry